Clinical trial
Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic…
NCT00291577 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00291577 |
|---|---|
| Title | Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer |
| Official title | Exploratory Evaluation Of A Sequential Administration Of Docetaxel And SU011248 In Women With Advanced Breast Cancer |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | Sunitinib (Sutent), Taxotere |
| Enrollment | 22 |
| Start date | Jul 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Feb 14, 2006 |
| Last update posted | Dec 23, 2009 |
| Countries | Belgium, Italy, Sweden |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: